Search results
Results from the WOW.Com Content Network
There are two scenarios in which the use of TCC is appropriate for managing neuropathic arthropathy (Charcot foot), according to the American Orthopaedic Foot and Ankle Society. [10] First, during the initial treatment, when the breakdown is occurring, and the foot is exhibiting edema and erythema; the patient should not bear weight on the foot ...
Jean-Martin Charcot (French: [ʒɑ̃ maʁtɛ̃ ʃaʁko]; 29 November 1825 – 16 August 1893) was a French neurologist and professor of anatomical pathology. [2] He worked on groundbreaking work about hypnosis and hysteria, in particular with his hysteria patient Louise Augustine Gleizes. [3]
[5] [6] It is named after those who classically described it: the Frenchman Jean-Martin Charcot (1825–1893), his pupil Pierre Marie (1853–1940), [7] and the Briton Howard Henry Tooth (1856–1925). [8] [9] There is no known cure. Care focuses on maintaining function. CMT was previously classified as a subtype of muscular dystrophy. [5]
There are so many potential health problems that can afflict the feet ? like ingrown toenails, bunions, blisters, and even gout.
Diabetic foot conditions can be acute or chronic complications of diabetes. [1] Presence of several characteristic diabetic foot pathologies such as infection, diabetic foot ulcer and neuropathic osteoarthropathy is called diabetic foot syndrome. The resulting bone deformity is known as Charcot foot.
Lee Christopher Rogers (born February 27, 1978) is an American podiatrist from San Antonio, Texas.He is most known for his work preventing amputations in diabetes and treating Charcot foot and he has helped define the qualifications of doctors of podiatric medicine and the privileging process for hospitals and surgery.
Total contact casting (TCC) is a specially designed cast designed to take weight off of the foot (off-loading) in patients with diabetic foot ulcers (DFUs). Reducing pressure on the wound by taking weight off the foot has proven to be very effective in DFU treatment.
Progressive muscular atrophy (PMA), also called Duchenne–Aran disease and Duchenne–Aran muscular atrophy, is a disorder characterised by the degeneration of lower motor neurons, resulting in generalised, progressive loss of muscle function.